Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer

NCT01965522 is registered in ClinicalTrials.gov with Juravinski Cancer Center as lead sponsor.

NCT NCT01965522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01965522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer
Lead sponsor
Juravinski Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
May 31, 2017
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

early stage breast cancer